A Case of Subungal Abscess and Onycholysis Induced by Docetaxel

Docetaxel is a taxoid antineoplastic drug, which is widely used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC). Among the adverse dermatological reactions, nail disorders such as bending, onycholysis, hypo- or hyperpigmentation are rare. We report a case of a 62-year-old male with advanced NSCLC (cT4N3M1, stage IV), who developed purulent discharge and onycholysis in the nail of all his fingers and the left great toe after five courses of anti-neoplastic chemotherapy, which included docetaxel (cumulative dose: 370 mg/m2, 590 mg). Seven days after the final session of chemotherapy, the patient had become aware of discoloration and swelling of the nail beds with out pain. Three days later, greenish-yellow purulent discharge oozed out from the involved nails. Microbiologic studies revealed Pseudomonas aeruginosa. Intravenous and topical antibiotics (mupirocin) were applied. After 2 weeks, regrown nails were observed and the onycholysis had improved. (Tuberc Respir Dis 2007; 62: 125-128)

keywords: Docetaxel, Onycholysis, Subungal abscess., Docetaxel, Onycholysis, Subungal abscess.

Reference

(2000) Phase II trial of docetaxel and vinorelbine in patients with advanced non-small-cell lung cancer,

(2001) Sequential chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil in patients with locally advanced head and neck cancer,

(1998) Kubista E. Onycholysis in patients treated with docetaxel. ,

(2000) Nail alterations secondary to paclitaxel therapy,

(2005) Erythema multiforme major following docetaxel,

(2003) Taxane-induced nail changes: incidence, clinical presentation and outcome,

(1999) Nail changes secondary to docetaxel,

(1997) Docetaxel-induced subungal hemorrhage,

(2003) A case of subungal abscess and onycholysis related to docetaxel,

10.

(2002) Docetaxel-induced nail dystrophy,

11.

(2002) Docetaxel-induced nail changes: a neurogenic mechanism: a case report,

12.

(2003) Carboplatin hypersensitivity reactions: retreatment with cisplatin desensitisation,

13.

(2005) Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand,

14.

(2005) Multicenter study of a frozen glove to prevent docetaxel-induced onycholysis and cutaneous toxicity of the hand,

바로가기메뉴

Article Contents

Vol.62 No.2

A Case of Subungal Abscess and Onycholysis Induced by Docetaxel

Abstract

Reference

Tuberculosis & Respiratory Diseases